CSI Market
Sign In | Register

Nuvation Bio Inc (NUVB) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access NUVB Annual Cash Flow →
Reviewing cash flow figures over time highlights how Nuvation Bio Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-57.44
Depreciation & amortization1.07
Amortization of Other Assets0.67
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories and Other Operating Assets8.49
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation19.49
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction-10.37
Stock Issued During Period Value New Issues-
Amortization Of Premium On Marketable Securities-
Marketable Securities Realized Gain Loss-
Change In Fair Value Of F P A Liability-
Transaction Costs-
Non Cash Lease Expense-0.07
Net Amortization On Marketable Securities-
Acquired In Process Research And Development-
Net Loss On Disposal Of Fixed Assets-
Amortization Of Premium And Discounts On Marketable Securities-0.84
Income taxes0.00
Marketable Securities, Gain (Loss), Excluding Other than Temporary Impairments, Total0.02
Accounts Receivable12.35
Increase (Decrease) in Accounts Payable3.11
Increase (Decrease) in Accrued Liabilities1.45
Increase (Decrease) in Security Deposits0.00
Increase (Decrease) in Prepaid Expense2.33
Other Working Capital-3.78
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-15.29
Discontinued operations0.00
Net Cash flow from Operating Activities-37.90
Investing Activities
Capital Expenditures-0.30
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities112.50
Payments to Acquire Marketable Securities-149.84
Real Estate Investments0.00
Transaction Costs Related To Anheart Acquisition-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-37.65
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-58.69
Long-term debt - borrowings243.75
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock4.41
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-18.90
Business Combination Separately Recognized Transactions Net Gains And Losses-
Deferred Financing Costs-
Advance Received From Broker-
Issuance Of Common Stock For Purchase Under Espp Value-
Proceeds From Issuance Of Common Stock Under Espp-
Proceeds From Revenue Interest Financing Agreement-0.86
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities170.57
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-38.20
Total Cash Flow94.52
4 historic quarters locked

Sign in to unlock the full Nuvation Bio Inc cash flow history.

Sign In Create Free Account

About Nuvation Bio Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-336646

Figures are derived from filed reports and may be restated. Historical data is subject to revision.